The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Flavio Vincenti

University of California

San Francisco

Kidney Transplant Service

San Francisco

USA

[email]@*.ucsf.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • University of California, San Francisco, Kidney Transplant Service, San Francisco, USA. 2002 - 2008
  • Departments of Medicine and Surgery, University of California, San Francisco, California, USA. 2003 - 2007

References

  1. Costimulation blockade in autoimmunity and transplantation. Vincenti, F. J. Allergy Clin. Immunol. (2008) [Pubmed]
  2. A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients. Vincenti, F., Schena, F.P., Paraskevas, S., Hauser, I.A., Walker, R.G., Grinyo, J. Am. J. Transplant. (2008) [Pubmed]
  3. T cell costimulation: a rational target in the therapeutic armamentarium for autoimmune diseases and transplantation. Vincenti, F., Luggen, M. Annu. Rev. Med. (2007) [Pubmed]
  4. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Vincenti, F., Friman, S., Scheuermann, E., Rostaing, L., Jenssen, T., Campistol, J.M., Uchida, K., Pescovitz, M.D., Marchetti, P., Tuncer, M., Citterio, F., Wiecek, A., Chadban, S., El-Shahawy, M., Budde, K., Goto, N. Am. J. Transplant. (2007) [Pubmed]
  5. Interleukin-2 receptor antagonist induction in modern immunosuppression regimens for renal transplant recipients. Vincenti, F., de Andrés, A., Becker, T., Choukroun, G., Cole, E., González-Posada, J.M., Kumar, M.A., Moore, R., Nadalin, S., Nashan, B., Rostaing, L., Saito, K., Yoshimura, N. Transpl. Int. (2006) [Pubmed]
  6. Antibodies come back to the forefront in transplantation. Vincenti, F. Clinical J. American Society Nephrology : Cjasn (2006) [Pubmed]
  7. Chronic induction. What's new in the pipeline. Vincenti, F. Contrib. Nephrol (2005) [Pubmed]
  8. Rationale and design of the DIRECT study: a comparative assessment of the hyperglycemic effects of tacrolimus and cyclosporine following renal transplantation. Vincenti, F., Rostaing, L. Contemporary. Clinical. Trials (2005) [Pubmed]
  9. Prospective, multicenter, randomized trial to compare incidence of new-onset diabetes mellitus and glucose metabolism in patients receiving cyclosporine microemulsion versus tacrolimus after de novo kidney transplantation. Vincenti, F., Tuncer, M., Castagneto, M., Klinger, M., Friman, S., Scheuermann, E.H., Wiecek, A., Russ, G.R., Martinek, A., Nonnast-Daniel, B. Transplant. Proc. (2005) [Pubmed]
  10. New insights into the pathogenesis and the therapy of recurrent focal glomerulosclerosis. Vincenti, F., Ghiggeri, G.M. Am. J. Transplant. (2005) [Pubmed]
  11. A multicenter, prospective study of C2-monitored cyclosporine microemulsion in a U.S. population of de novo renal transplant recipients. Vincenti, F., Mendez, R., Curtis, J., Light, J., Pearson, T., Wu, Y.M., Katz, S.M., Akalin, E., Esterl, R., Gugliuzza, K., Shihab, F., Jordan, S., Jonsson, J., Molmenti, E., Barbeito, R. Transplantation (2005) [Pubmed]
  12. Optimizing the use of cyclosporine (Neoral) for recipients of living donor kidneys. Vincenti, F., Brennan, T.V., Fuller, T.F., Feng, S. Transplant. Proc. (2004) [Pubmed]
  13. Interleukin-2 receptor antagonists and aggressive steroid minimization strategies for kidney transplant patients. Vincenti, F. Transpl. Int. (2004) [Pubmed]
  14. Pharmacokinetic and pharmacodynamic studies of one or two doses of daclizumab in renal transplantation. Vincenti, F., Pace, D., Birnbaum, J., Lantz, M. Am. J. Transplant. (2003) [Pubmed]
  15. Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil. Vincenti, F., Monaco, A., Grinyo, J., Kinkhabwala, M., Roza, A. Am. J. Transplant. (2003) [Pubmed]
  16. De novo use of sirolimus in immunosuppression regimens in kidney and kidney-pancreas transplantation at the University of California, San Francisco. Vincenti, F., Stock, P. Transplant. Proc. (2003) [Pubmed]
  17. New monoclonal antibodies in renal transplantation. Vincenti, F. Minerva. Urol. Nefrol (2003) [Pubmed]
  18. Immunosuppression minimization: current and future trends in transplant immunosuppression. Vincenti, F. J. Am. Soc. Nephrol. (2003) [Pubmed]
  19. What's in the pipeline? New immunosuppressive drugs in transplantation. Vincenti, F. Am. J. Transplant. (2002) [Pubmed]
 
WikiGenes - Universities